Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice.

Authors:
Nozomi Yabuuchi Huixian Hou Nao Gunda Yuki Narita Hirofumi Jono Hideyuki Saito

Int J Mol Sci 2021 Feb 10;22(4). Epub 2021 Feb 10.

Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan.

Endogenous factors involved in the progression of cisplatin nephropathy remain undetermined. Here, we demonstrate the toxico-pathological roles of indoxyl sulfate (IS), a sulfate-conjugated uremic toxin, and sulfotransferase 1A1 (SULT1A1), an enzyme involved in its synthesis, in cisplatin-induced acute kidney injury using -deficient ( KO) mice. With cisplatin administration, severe kidney dysfunction, tissue damage, and apoptosis were attenuated in (KO) mice. Aryl hydrocarbon receptor (AhR) expression was increased by treatment with cisplatin in mouse kidney tissue. Moreover, the downregulation of antioxidant stress enzymes in wild-type (WT) mice was not observed in (KO) mice. To investigate the effect of IS on the reactive oxygen species (ROS) levels, HK-2 cells were treated with cisplatin and IS. The ROS levels were significantly increased compared to cisplatin or IS treatment alone. IS-induced increases in ROS were reversed by downregulation of AhR, xanthine oxidase (XO), and NADPH oxidase 4 (NOX4). These findings suggest that SULT1A1 plays toxico-pathological roles in the progression of cisplatin-induced acute kidney injury, while the IS/AhR/ROS axis brings about oxidative stress.

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms22041764DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916706PMC
February 2021

Publication Analysis

Top Keywords

acute kidney
12
cisplatin-induced acute
12
kidney injury
12
toxico-pathological roles
8
indoxyl sulfate
8
ros levels
8
kidney
5
cisplatin
5
mice
5
attenuated mice
4
apoptosis attenuated
4
mice cisplatin
4
damage apoptosis
4
levels hk-2
4
xanthine oxidase
4
hydrocarbon receptor
4
receptor ahr
4
ahr xanthine
4
aryl hydrocarbon
4
mice aryl
4

Keyword Occurance

Similar Publications

Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.

Authors:
Vanderlene L Kung Rana Sandhu Mark Haas Edmund Huang

Kidney Int 2021 Apr 7. Epub 2021 Apr 7.

Division of Nephrology, Department of Medicine, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.

Chronic active T cell-mediated rejection (CA TCMR) is a newly described variant of kidney allograft rejection associated with long-term graft loss. Whether this form of rejection is related to under immunosuppression is debated and the benefit of immunosuppressive therapy in CA TCMR is unknown. Here we investigate the amenability of CA TCMR to treatment and examine the impact of clinical, histologic, and molecular parameters on outcomes. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Isorhynchophylline ameliorates paraquat-induced acute kidney injury by attenuating oxidative stress and mitochondrial damage via regulating toll-interacting expression.

Authors:
Qiang Zheng Yuan Zhang Zheng Zhao Haitao Shen Hongyu Zhao Min Zhao

Toxicol Appl Pharmacol 2021 Apr 7:115521. Epub 2021 Apr 7.

Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, China. Electronic address:

Isorhynchophylline (IRN) is an alkaloid with anti-inflammatory and anti-oxidative activities in cardiovascular and brain diseases, but its role in paraquat (PQ)-induced acute kidney injury (AKI) is yet unknown. The model of PQ-induced AKI in rats was established by intraperitoneal injection of PQ (25 mg/kg). We found that the tail vein injection of IRN (4 mg/kg) significantly increased the survival rate of PQ-intoxicated rats. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome.

Authors:
Allison Kwong W Ray Kim Paul Y Kwo Uerica Wang Xingxing Cheng

Liver Transpl 2021 Apr 10. Epub 2021 Apr 10.

Stanford University, Division of Nephrology.

Background & Aims: Vasoconstrictors are the treatment of choice for hepatorenal syndrome (HRS), a potentially lethal complication of end-stage liver disease. We evaluate the real-life effectiveness of a sequential vasoconstrictor regimen of midodrine-octreotide followed by norepinephrine in a non-ICU setting in the United States, where terlipressin is not available.

Approach & Results: Adult patients diagnosed with HRS were treated with oral midodrine and subcutaneous octreotide in conjunction with albumin. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

[Deafness after COVID-19? German version].

Authors:
K Gerstacker I Speck S Riemann A Aschendorff A Knopf S Arndt

HNO 2021 Apr 9. Epub 2021 Apr 9.

Klinik für Hals‑, Nasen- und Ohrenheilkunde, Universitätsklinikum Freiburg, Killianstraße 5, 79106, Freiburg, Deutschland.

This article presents a case of sudden bilateral deafness in the context of a severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection and resultant coronavirus disease 2019 (COVID-19). After treatment in the intensive care unit for acute respiratory distress syndrome and acute kidney failure, hearing ability had drastically changed. While hearing had been subjectively normal before the infection, deafness was now measured on the left and profound hearing loss on the right ear. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Sinusoidal Obstruction Syndrome in Critically Ill Patients in the Era of Defibrotide: A Retrospective Multicenter Study.

Authors:
Pierre-Edouard Debureaux Michael Darmon Naïke Bige Anne Sophie Moreau Djamel Mokart Guillaume Morel Claire Lacan Pierre Perez Frédéric Pene Achille Kouatchet Muriel Picard Martin Murgier Florent Wallet Julien Mayaux Emmanuel Canet Elie Azoulay Sandrine Valade

Transplant Cell Ther 2021 Apr 17;27(4):338.e1-338.e7. Epub 2020 Dec 17.

Medical Intensive Care Unit, Saint Louis Hospital, Paris, France.

Sinusoidal obstruction syndrome (SOS) is a life-threatening liver complication of high- dose chemotherapy. Defibrotide is the only available therapeutic option approved for SOS. The prognosis of SOS in patients requiring intensive care unit (ICU) admission remains unknown. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap